Eric Morgen's most recent trade in BioAge Labs Inc. was a trade of 200,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BioAge Labs Inc. | Eric Morgen | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| BioAge Labs Inc. | Eric Morgen | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| BioAge Labs Inc. | Eric Morgen | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2024 | 257,973 | 257,973 | - | - | Stock Option (Right to Buy) | |
| BioAge Labs Inc. | Eric Morgen | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2024 | 13,598 | 13,598 | - | - | Stock Option (Right to Buy) | |
| BioAge Labs Inc. | Eric Morgen | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2024 | 4,952 | 4,952 | - | - | Stock Option (Right to Buy) |